John Doyle
Director of Finance/CFO at COGNITION THERAPEUTICS, INC.
Net worth: 236 280 $ as of 2024-03-30
Profile
John Doyle's current job is as the Chief Financial & Accounting Officer at Cognition Therapeutics, Inc. He previously worked as the Director-Business Unit Financial Planning at PAREXEL International Corp.
from 2015 to 2016.
In 2021, he served as the Chief Financial Officer, Treasurer & Senior VP at Chiasma, Inc. From 2019 to 2020, he was the Vice President-Finance & Investor Relations at Verastem, Inc. He also held the position of Head-Financial Planning & Analysis at SimpliVity Corp.
from 2016 to 2018.
In 2022, he worked as the Chief Financial Officer at 4D Pharma Plc.
Mr. Doyle completed his undergraduate degree at the University of Massachusetts.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-14 | 129,824 ( 0.33% ) | 236 280 $ | 2024-03-30 |
John Doyle active positions
| Companies | Position | Start |
|---|---|---|
| COGNITION THERAPEUTICS, INC. | Director of Finance/CFO | 2023-04-30 |
Former positions of John Doyle
| Companies | Position | End |
|---|---|---|
| 4D PHARMA PLC | Director of Finance/CFO | 2023-03-29 |
| CHIASMA, INC. | Director of Finance/CFO | 2021-08-04 |
| VERASTEM, INC. | Director of Finance/CFO | 2018-08-27 |
SimpliVity Corp.
 SimpliVity Corp. Information Technology ServicesTechnology Services SimpliVity Corp. provides hyperconverged infrastructure that accelerates the deployment of resources and workloads. Its product OmniCube delivers the economies of scale of a cloud computing model while still ensuring enterprise information technology (IT) performance and resiliency for virtual workloads. It services include data center consolidation, data protection, disaster recovery, cloud computing, and data migration services. The company was founded by Doron Kempel and Steve Bagby in 2009 and is headquartered in Westborough, MA. | Corporate Officer/Principal | 2018-01-31 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | 2016-03-31 |
Training of John Doyle
| University of Massachusetts | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| COGNITION THERAPEUTICS, INC. | Health Technology |
| VERASTEM, INC. | Health Technology |
| 4D PHARMA PLC | Health Technology |
| Private companies | 3 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Chiasma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of oral forms of therapies that are available by injection. Its products include octreotide capsules. The company was founded by Shmuel A. Ben-Sasson and Guy Yachin in 2001 and is headquartered in Needham, MA. | Health Technology |
SimpliVity Corp.
SimpliVity Corp. Information Technology ServicesTechnology Services SimpliVity Corp. provides hyperconverged infrastructure that accelerates the deployment of resources and workloads. Its product OmniCube delivers the economies of scale of a cloud computing model while still ensuring enterprise information technology (IT) performance and resiliency for virtual workloads. It services include data center consolidation, data protection, disaster recovery, cloud computing, and data migration services. The company was founded by Doron Kempel and Steve Bagby in 2009 and is headquartered in Westborough, MA. | Technology Services |
- Stock Market
- Insiders
- John Doyle
